Mandel: House settlement clearinghouse won't create CFB's goal for more level playing field
With the House vs. NCAA settlement approved, college athletics is about to begin the latest chapter in its long history of attempting to interfere with the market for athletes' services.
Let's see if this version holds up better in court than all the ones before it.
As you know by now, the House settlement has given birth to a new system by which schools for the first time can directly pay their athletes up to $20.5 million this coming school year. The schools will insist these are purely NIL deals and do not constitute 'pay-for-play,' but of course, they are entirely contingent on the athlete playing for that university. And that's fine. Nothing wrong with paying someone for their services.
Advertisement
But where the settlement veers into outright market manipulation is the establishment of a new NIL Go clearinghouse, operated by Deloitte, by which athletes must submit all deals they receive from outside sources that exceed $600. Which, in the major sports, is pretty much all of them. If Deloitte deems, say, a running back's $1 million deal from a school's collective to be above 'fair market value,' he cannot accept it.
In every other industry in this country, 'fair market value' is whatever someone is willing to pay you. Just ask the many mediocre football coaches who make $6-8 million a year. Or the athletic directors who make $1.2 million a year to hire those mediocre coaches. No clearinghouse for those folks.
Every legal expert I've spoken with about this subject thinks there's little chance this clearinghouse would survive a legal challenge. It sure sounds like yet another instance of competitors (in this case, the Power conferences) conspiring to limit athletes' compensation. Go back and read the Supreme Court decision in Alston v. NCAA to see how the highest court in the land feels about restrictions on athletes' compensation.
It's somewhat poetic the House settlement got approved during Game 3 of the WCWS, where $1M pitcher NiJaree Canady nearly led Texas Tech to an improbable national title.
Because the purpose of the new Deloitte NIL clearinghouse is to stamp out collectives like Texas Tech's.
— Stewart Mandel (@slmandel) June 7, 2025
Nevertheless, the Power conferences — it's them, not the NCAA driving this — are pressing ahead. On Monday, they proudly unveiled their newly created enforcement entity, the College Sports Commission, led by former Major League Baseball executive Bryan Seeley, who is likely being paid seven figures to make sure college athletes stop getting paid seven figures. Presumably, they've consulted with their lawyers, who have told them the thing is ironclad. The next Judge Wilken will be totally fine with it.
By now, you may be asking yourself, 'Why are they doing this? Who exactly is being harmed by a transfer quarterback getting $3 million from a school's collective?' Athletes going into the portal at any moment is an understandable source of frustration, but the House settlement does nothing to address that issue. It just wants to curb how much one gets for going into the portal.
Advertisement
The stated reason, as Nick Saban, for one, has said 1,000 times, is the need for a 'level playing field.' It's not 'fair' that Texas Tech has an oil billionaire willing to spend $10 million-plus on the transfer portal if Alabama doesn't have one. How many times have we heard: This is not what NIL is intended for.
It doesn't particularly matter at this point what NIL was intended for. This is what it's become. Collectives became a thing specifically because schools didn't want anything to do with paying athletes. Now that they're forced to, they want to unwind time and reverse things.
But what's really rich is the whole 'level playing field' thing.
There has never, ever been a level playing field in college recruiting. The schools with the most money have always held an advantage over everyone else. They have the most history, the biggest stadiums, the best-paid coaches and the most lavish facilities. Ohio State was dominating Purdue in recruiting long before there were ever NIL collectives, and the Buckeyes will keep dominating in the revenue-sharing era. You could set the cap at $60.5 million, not $20.5 million, and there's still no scenario where the Boilermakers would be able to outspend the Buckeyes.
Meanwhile, people have been so busy the past few years shouting that the sky is falling that they've failed to notice that NIL may be the first development in history that's actually given a larger pool of teams a chance at landing top talent.
The top quarterback in the portal this offseason, Tulane's Darian Mensah, did not go to Georgia or Ohio State. He chose Duke, where he's getting a reported $4 million NIL deal. The nation's No. 1 men's basketball recruit, A.J. Dybantsa, is not going to North Carolina or Kansas; he's going to BYU, for a reported $5 million deal. And last year, softball phenom NiJaree Canady turned down that sport's biggest juggernaut, Oklahoma, in favor of Texas Tech, which gave her that sport's first-ever seven-figure deal. Earlier this month, she and her team ended the Sooners' reign — and she signed another deal.
Advertisement
All of those deals got done before the House settlement was approved. Had they not, theoretically, Deloitte could flag them for being too far above 'market value.'
Clearly, booster-driven collectives aren't going away. If Oracle founder Larry Ellison wants to give the next Michigan quarterback recruit $4 million, it seems highly unlikely someone could tell him no. Either the collectives will get more creative in how they structure their deals, or someone is going to sue and succeed in getting an injunction.
Neither the schools nor the athletes would be the ones filing that suit because they're bound by the settlement. But boosters aren't bound by it. Companies aren't bound by it. And, most concerning to the conferences, state attorneys general aren't bound by it. They're the folks who succeeded in getting both the NCAA's booster restrictions and transfer restrictions shot down.
We know this much: Most schools that plan to offer the maximum $20.5 million in House payments are following a formula by which they'll allocate around $13 million for football and $3 million for men's basketball. Ohio State last year spent $20 million on football alone, and many schools are spending way more than that this year. Kentucky is one of several programs planning to spend more than $10 million on men's basketball.
Coaches' and administrators' salaries have only gone up and up and up over time, but the powers that be seem to think they can make athletes' unofficial salaries go down with their magic clearinghouse.
That's not generally how markets work.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
2 High-Yield Healthcare Dividend Stocks to Buy Hand Over Fist in June
The average healthcare stock has a yield of just 1.7%. Medtronic's dividend yield is 3.3%. Alexandria Real Estate Equities' yield is 7.4%. 10 stocks we like better than Medtronic › The healthcare sector isn't exactly known for offering huge yields, with Health Care Select Sector SPDR (NYSEMKT: XLV) offering a yield of just 1.7%. If dividend investors take some time to dig into the sector, however, they can do much better. For example, Medtronic (NYSE: MDT) has a 3.3% yield today, and Alexandria Real Estate Equities (NYSE: ARE) is offering a yield of 7.4%. Here's what you need to know about each of these high-yield healthcare stocks. Medtronic makes medical devices. It is one of the largest competitors in the space, making products across the cardiovascular, neuroscience, medical surgical, and diabetes categories. It has a leading position in each of the areas in which it operates, and it operates on a global scale. That said, the last few years haven't been the best ones for the company. Innovation, which is highly important in the healthcare space, can be lumpy. And given Medtronic's size, the business has become a little cumbersome. Growth has stalled out, and profitability has come under pressure. Investors have focused on the negatives pushing the shares lower and the dividend yield up toward the high end of Medtronic's historical yield range. If you are a dividend investor that thinks in decades and not days, however, this is likely to be an investment opportunity. The company's innovation pipeline is starting to turn into new-product introductions. As new products gain traction, financial performance is likely to improve. And management has been working to streamline the business with cost cuts and a move to refocus on its most profitable operations. To that end, the company is set to spin off its lower-margin diabetes division in 2026. The move is expected to be immediately accretive to earnings, and the dividend policy isn't expected to change. All in, Medtronic is doing what it needs to do to get back on the growth path. And that should support continued dividend increases; the medical device maker only has two years to go before it hits Dividend King status (50+ years of annual dividend increases). June could be an opportune time to buy the stock hand over fist. Alexandria is a real estate investment trust (REIT), which seems pretty far away from healthcare. Its primary focus is on office properties, which also seems a bit removed from healthcare. The key here is that the REIT owns biomedical research facilities, which combine research space and office space in one property. Both are important to each other since the research takes place in specialized space, while the analysis of that research takes place in a normal office environment. Alexandria is one of the largest pure play medical research REITs you can buy. Alexandria counts some of the largest and most important medical research groups as tenants, from both the private side of the equation and the government side. However, like any landlord, the REIT's revenues will be impacted by the occupancy levels of its properties. And those rise and fall over time. Right now, occupancy is relatively weak, dropping to 91.7% at the end of the first quarter of 2025 from 94.6% at the end of 2024. Swings like this happen from time to time, but Wall Street is treating Alexandria as if its dividend is at a material risk of being cut. Only the funds from operations (FFO) payout ratio in the first quarter was a fairly strong 57%. There's room for adversity before a dividend cut would be in order. To be fair, office properties, and particularly highly specialized office properties, tend to have higher operating costs than other real estate assets. But it seems highly likely that Alexandria will manage its way through this weak patch and continue to extend its 15-year streak of annual dividend increases. For income lovers, this healthcare REIT is worth a deep dive in June. The average healthcare stock has an uninspiring dividend yield. But the average is made up of many different companies, some of which actually have very attractive dividend yields. That list includes industry-leading companies like Medtronic and Alexandria Real Estate. You might just want to pick up shares in one, or both, of these high yielders before June is over after you get to know them a little better. Before you buy stock in Medtronic, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Medtronic wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $664,089!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $881,731!* Now, it's worth noting Stock Advisor's total average return is 994% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Reuben Gregg Brewer has positions in Medtronic. The Motley Fool has positions in and recommends Alexandria Real Estate Equities. The Motley Fool recommends Medtronic and recommends the following options: long January 2026 $75 calls on Medtronic and short January 2026 $85 calls on Medtronic. The Motley Fool has a disclosure policy. 2 High-Yield Healthcare Dividend Stocks to Buy Hand Over Fist in June was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
28 minutes ago
- Yahoo
Tulare County home listings asked for less money in May - see the current median price here
The median home in Tulare County listed for $419,975 in May, slightly down from the previous month's $421,778, an analysis of data from shows. Compared to May 2024, the median home list price slightly decreased from $424,975. The statistics in this article only pertain to houses listed for sale in Tulare County, not houses that were sold. Information on your local housing market, along with other useful community data, is available at Tulare County's median home was 1,774 square feet, listed at $244 per square foot. The price per square foot of homes for sale is up 1.6% from May 2024. Listings in Tulare County moved steadily, at a median 44 days listed compared to the May national median of 51 days on the market. In the previous month, homes had a median of 43 days on the market. Around 352 homes were newly listed on the market in May, a 15% increase from 306 new listings in May 2024. The median home prices issued by may exclude many, or even most, of a market's homes. The price and volume represent only single-family homes, condominiums or townhomes. They include existing homes, but exclude most new construction as well as pending and contingent sales. In California, median home prices were $775,000, a slight increase from April. The median California home listed for sale had 1,775 square feet, with a price of $477 per square foot. Throughout the United States, the median home price was $440,000, a slight increase from the month prior. The median American home for sale was listed at 1,840 square feet, with a price of $234 per square foot. The median home list price used in this report represents the midway point of all the houses or units listed over the given period of time. Experts say the median offers a more accurate view of what's happening in a market than the average list price, which would mean taking the sum of all listing prices then dividing by the number of homes sold. The average can be skewed by one particularly low or high price. The USA TODAY Network is publishing localized versions of this story on its news sites across the country, generated with data from Please leave any feedback or corrections for this story here. This story was written by Ozge Terzioglu. Our News Automation and AI team would like to hear from you. Take this survey and share your thoughts with us. This article originally appeared on Visalia Times-Delta: Tulare County home listings asked for less money in May - see the current median price here
Yahoo
29 minutes ago
- Yahoo
Wall Street Says Supermicro Stock Could Gain 60% in a Year
Super Micro Computer (SMCI) has weathered significant volatility in recent times, with its stock experiencing a rollercoaster ride. After reaching significant highs, the stock experienced steep declines due to a range of concerns, including allegations of accounting irregularities and a delay in filing its financial reports with the SEC. Nonetheless, SMCI stock has made an impressive recovery recently, climbing 50% year-to-date. 3 ETFs with Dividend Yields of 12% or Higher for Your Income Portfolio Dear Tesla Stock Fans, Mark Your Calendars for June 30 Nvidia Is Quickly Approaching a New Record High. Is It Too Late to Buy NVDA Stock? Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today! Supermicro's stock came under heavy pressure following headlines that shook investor confidence. Allegations of accounting irregularities and a delay in filing annual reports sparked concerns about the possibility of delisting from the Nasdaq Exchange. The company eventually filed its financials, avoiding that outcome, but the damage to investor sentiment was already done. Adding to this were disappointing quarterly earnings. For its fiscal Q3 2025, Supermicro reported $4.6 billion in revenue, a 19% increase year-over-year but a 19% drop quarter-over-quarter. The results missed Wall Street's expectations, mainly due to customers holding back purchases amid uncertainty around new AI platform transitions, particularly Nvidia's (NVDA) move from Hopper to Blackwell GPU architecture. These delays contributed to the shortfall in expectations and added further pressure on the stock. These issues, however, now appear to be in the rearview mirror as those delays are beginning to turn into future growth opportunities. As customers resume spending, Supermicro appears poised to regain momentum. Furthermore, Supermicro recently announced a $20 billion partnership with Saudi Arabia-based DataVolt, which significantly boosted its stock. This deal strengthens the company's demand pipeline and will support future growth. Given these positive developments and continued investments in artificial intelligence (AI) infrastructure, SMCI stock is likely to trend higher. The highest price target for Supermicro stock is $70, courtesy of Loop Capital analyst Ananda Baruah. This target implies nearly 60% upside potential from here. Supermicro is well-positioned to benefit from secular tailwinds in the AI infrastructure market. The company specializes in building high-performance server and storage systems, many of which are now tailored specifically for AI workloads. This provides a significant runway for growth, as it strengthens the company's position to capitalize on AI demand. Thanks to the solid demand, over 70% of Supermicro's total revenue is now derived from AI GPU platforms, reflecting that the company could deliver significant growth as investments in AI continue to rise. Further, to meet the growing demand, Supermicro continues to expand its product portfolio. It has ramped up the production of its Data Center Building Block Solutions (DCBBS), which offer energy-efficient systems for next-generation computing. The company continues to roll out new products, including a range of air-cooled and liquid-cooled AI systems and racks. It has broadened its platform support to include AMD's newest AI accelerators. The expansion of SMCI's product portfolio is expected to help drive its market share higher. Supermicro is strengthening its leadership in the high-performance computing space with its technology to reduce environmental impact. The company's direct liquid cooling (DLC) technology helps lower energy costs, a critical factor as AI workloads become increasingly power-hungry. Furthermore, the rollout of its second-generation DLC-2 system will offer improved energy efficiency and thermal performance, which is expected to drive demand. Moreover, Supermicro's DCBBS reduces the time and complexity involved in building modern data centers. As the demand for scalable, plug-and-play infrastructure grows, DCBBS could become a significant growth driver for the company. The growing use of AI, which requires enhanced data center capabilities, will substantially increase demand for Supermicro's products. Supermicro's ability to design and deliver customized hardware solutions will help meet the specific needs of AI-driven workloads, strengthening its competitive positioning. Moreover, its focus on innovation, including energy-efficient green computing products and enhanced production of its DCBBS, positions it well to gain a higher market share. Analysts maintain a 'Moderate Buy' consensus rating on SMCI stock. However, given the strength of its product lineup and the booming demand in the AI and data center spaces, it wouldn't be surprising to see Supermicro's stock push toward the $70 mark in the near future. On the date of publication, Amit Singh did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
